🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety of Sabin Inactivated Po...
Status
Completed
Location
Gaoan Center for Disease Control and Prevention
Start Date
2022-06-13
Trial ID
NCT05432141
Treatments Being Tested
The purpose of the study is to evaluate the immunogenicity and safety of Ki...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03-31
Trial ID
NCT00871117
Treatments Being Tested
The purpose of this study is to determine whether vYF (investigational vacc...
Status
Recruiting
Location
Investigational Site Number : 3400001
Start Date
2025-07-11
Trial ID
NCT07103148
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-07-01
Trial ID
NCT02058563
Treatments Being Tested
This is a prevalence study of protective antibodies to measles, mumps, and ...
Status
Completed
Location
Maharaj Nakorn Chiang Mai Hospital, Department of Medicine, Chiang Mai University
Start Date
2011-07
Trial ID
NCT02724852
Treatments Being Tested
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0018)
Start Date
2017-10-17
Trial ID
NCT03239873
Treatments Being Tested
This phase 3b study will compare the immunogenicity and reactogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-04-01
Trial ID
NCT00871000
Treatments Being Tested
Assess the safety and immunogenicity of a 3-dose schedule (at 2, 4, 6 month...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-11
Trial ID
NCT02173704
Treatments Being Tested
To evaluate the safety and immunogenicity of GSK Biologicals' live attenuat...
Status
Completed
Location
Multiple Locations
Start Date
2000-11
Trial ID
NCT00388440
Treatments Being Tested
This is a study to evaluate the immune response and safety of GSK Biologica...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-10-06
Trial ID
NCT00197015